CompletedPhase 2NCT00764595

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

Studying Gastrointestinal stromal tumor

Last synced from ClinicalTrials.gov May 9, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Principal Investigator: Tatsuo Kanda, MD
Niigata University Medical & Dental Hospital
Intervention: imatinib mesylate(drug)
Enrollment: 5 enrolled
Eligibility: 20 years · All sexes
Timeline: 2008 – 2016

Study locations (30)

Aichi Cancer Center, Nagoya, Aichi-ken, Japan
Aichi Medical University, Nagoya, Aichi-ken, Japan
Hirosaki University, School of Medicine, Hirosaki, Aomori, Japan
National Hospital Organization Kure Medical Center, Kure, Hiroshima, Japan
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
International Goodwill Hospital, Yokohama, Kanagawa, Japan
Kochi Medical School, Nankoku, Kochi, Japan
Kyoto Second Red Cross Hospital, Kanigyou-ku, Kyoto, Japan
University of Miyazaki Hospital, Kiyotake, Miyazaki, Japan
Niigata Prefectural Central Hospital, Jōetsu, Niigata, Japan
Nagaoka Chuo General Hospital, Nagaoka, Niigata, Japan
Oita University Hospital, Yufu, Oita Prefecture, Japan
Kawasaki Medical School, Kurashiki, Okayama-ken, Japan
Ryukyu University Hospital, Nishiharacho, Okinawa, Japan
+15 more locations on ClinicalTrials.gov

Collaborators

Niigata University Medical & Dental Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00764595 on ClinicalTrials.gov

Other trials for Gastrointestinal stromal tumor

Additional recruiting or active studies for the same condition.

See all trials for Gastrointestinal stromal tumor →

← Back to all trials